KA
Kofi A. Anie

Publications (1)

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
Article scientifique · 2018

Domaines principaux

Sciences de la santé1

Statistiques

Consultations2
Téléchargements0